Aeterna submits NDA for AGHD diagnostic

Aeterna Zentaris Inc. (TSX:AEZ; NASDAQ:AEZS) submitted an NDA to FDA for Solorel macimorelin ( AEZS-130) to diagnose adult growth hormone deficiency (GHD). The product is an oral ghrelin-mimetic growt...